Clinical Trials · NCT01740921
GLP-1 and Microvascular Function in Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Royal Devon and Exeter NHS Foundation Trust
- Enrollment
- 39
- Start date
- Jan 2011
- Locations
- 1 site, United Kingdom
- Primary endpoint
- change of baseline skin maximum hyperaemia at 4 months